Your session is about to expire
← Back to Search
Integrated Treatment for Smoking Cessation After Acute Coronary Syndrome
Study Summary
This trial will test whether a single, integrated treatment that targets both depressed mood and smoking is more effective than usual care in reducing post-acute coronary syndrome mortality.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am currently in counseling for depression or to quit smoking.I am open to quitting smoking after leaving the hospital.I have access to a phone or am willing to use one provided by the study.I was hospitalized for acute coronary syndrome (ACS) within the last 30 days.You smoked at least one cigarette per day before being hospitalized.You are not expected to live for more than 6 months, based on a risk calculator.I have some difficulties making decisions due to my mental health.I am between 18 and 75 years old.You have a serious mental illness that would make it hard for you to take part in the study, or you have thoughts of harming yourself.
- Group 1: Smoking Cessation and Health & Wellness
- Group 2: BAT-CS
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Which population would be best suited to participate in this experiment?
"For this trial, 324 individuals aged 18 to 75 with a recent diagnosis of acute coronary syndrome are required. These participants must also possess the following attributes: fluency in English, smoking history of at least 1 cigarette per day prior to hospitalization, inpatient status, access to or willingness to use a study issued cell phone and agreement for consenting all trial procedures including potential quitting from smoking upon discharge."
Is the enrollment process for this clinical research still open?
"Indeed, clinicaltrials.gov has verified that this trial is actively searching for volunteers to join their study. This experiment was initially posted on January 29th 2018 and the latest update occurred on August 2nd 2022."
Is eligibility for this research endeavor limited to persons aged 60 and over?
"The age range of eligible patients for this study is between 18 years old and 75 years old."
What is the projected enrolment size of this research endeavor?
"Affirmative. The details hosted on clinicaltrials.gov suggest that this experiment, which was first introduced to the public on 29th January 2018 is currently in need of enrolment. A total of 324 patients are required from 1 medical facility."
What objectives does this experiment seek to achieve?
"This clinical trial will run for 12 months with the main objective of evaluating Depression Symptoms. Secondary objectives include testing Blood Bio-markers (HDL, LDL, High Sensitivity C-reactive protein and Fibrinogen), determining Resting Systolic and Diastolic Blood Pressure levels, as well as assessing Treatment Acceptability through a Client Satisfaction Questionnaire."
Who else is applying?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger